Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer

Table 1

Clinical data of GC patients () obtained from The Cancer Genome Atlas.

Variables	Patients, (%)
Sex	443
Male	285 (64.33%)
Female	158 (35.67%)
Age (years)
≤65	197 (44.47%)
>65	241 (54.4%)
Grade
G1	12 (2.7%)
G2	159 (35.89%)
G3	263 (59.36%)
Gx	9 (2.03%)
TNM stage
I	59 (13.31%)
II	130 (29.34%)
III	183 (41.30%)
IV	44 (9.93%)
Unknown	28 (6.32%)
T stage
T1	23 (5.19%)
T2	93 (20.99%)
T3	198 (44.69%)
T4	119 (26.86%)
TX	10 (2.25%)
N stage
N0	132 (29.79%)
N1	119 (26.86%)
N2	85 (19.18%)
N3	88 (19.86%)
NX	17 (3.83%)
Unknown	2 (0.45%)
M stage
M0	391 (88.26%)
M1	30 (6.77%)
MX	22 (4.49%)

TX, NX, and MX are unknown cancer stages.